| Analysis of PSA, biopsy uptake predictive value and associated death in a prostate cancer screening programme |
Mathieu Boniol |
International Prevention Research Institute |
PLCO |
Dec 11, 2012 |
PLCO-8 |
| Reconciling results of PSA screening efficacy using PLCO and ERSPC data: CISNET modeling project |
Ruth Etzioni |
Fred Hutchinson Cancer Research Center |
PLCO |
Dec 11, 2012 |
PLCO-9 |
| BMI and risks of pancreatic cancer and multiple myeloma mortality in the African American BMI Pooling Project |
Cari Kitahara |
NCI, DCEG, NEB |
PLCO |
Dec 7, 2012 |
PLCO-7 |
| Validation of a Risk Assessment Decision Rule for Epithelial Ovarian Cancer |
Nicole Urban |
Fred Hutchinson Cancer Research Center |
PLCO |
Dec 3, 2012 |
PLCO-6 |
| Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to thyroid cancer risk in the PLCO study |
Melissa Braganza |
NCI, DCEG, REB |
PLCO |
Nov 20, 2012 |
PLCO-5 |
| Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to glioma in the PLCO study |
Melissa Braganza |
NCI, DCEG, REB |
PLCO |
Nov 20, 2012 |
PLCO-4 |
| Benign breast and reproductive conditions and thyroid cancer |
Melissa Braganza |
NCI, DCEG, REB |
PLCO |
Nov 20, 2012 |
PLCO-2 |
| follow-up of abnormal CA 125 levels in patients in the PLCO trial |
Keith Terada |
University of Hawaii |
PLCO |
Nov 14, 2012 |
PLCO-3 |
| Thyroid Cancer and NSAIDs: A Pooled Analysis |
Naris Nilubol |
NCI, CCR, EOB |
PLCO |
Nov 2, 2012 |
PLCO-1 |
| Validation of Biomarker Panel for Classification of Indeterminate Pulmonary Nodules |
Charles Birse |
Celera |
PLCO |
Oct 23, 2012 |
2012-0222 |
| Circulating inflammation markers and risk of lung cancer: A replication study |
Meredith Shiels |
NCI |
PLCO |
Oct 22, 2012 |
2012-0356 |
| Expression levels and prostate cancer recurrence in PLCO |
Michael Cook |
NCI |
PLCO |
Oct 22, 2012 |
2012-0312 |
| Validation of protein biomarker signatures of prostate cancer aggressiveness |
Stephen Schmechel |
University of Minnesota |
PLCO |
Oct 22, 2012 |
2012-0286 |
| Epigenetic Variation at 8q24 and Prostate Cancer Risk |
Kathryn Barry |
University of Maryland School of Medicine |
PLCO |
Oct 22, 2012 |
2012-0282 |
| Blood-based gene expression markers for early detection of lung cancer |
Melissa Rotunno |
NCI, DCEG, GEB |
PLCO |
Oct 22, 2012 |
2012-0247 |
| Pancreas Cancer Early Detection |
Paul Lampe |
Fred Hutchinson Cancer Research Center |
PLCO |
Oct 22, 2012 |
2012-0229 |
| Identifying metabolomic risk factors for pancreatic cancer |
Rachael Stolzenberg-Solomon |
NCI, DCEG, NEB |
PLCO |
Sep 5, 2012 |
2012-0066 |
| Endometrial thickness and risk of hormone-related malignancies |
Ashley Felix |
NCI, DCEG, HREB |
PLCO |
Aug 30, 2012 |
2012-0352 |
| Evaluation of a four kallekrein panel to detect prostate cancer |
Hans Lilja |
Other (Specify) |
PLCO |
Aug 15, 2012 |
2010-0042 |
| Ovarian cancer risk factors by histologic subtypes and development of an ovarian cancer risk prediction model in the Ovarian Cancer Cohort Consortium (OC3) |
Nicolas Wentzensen MD |
NCI, DCEG, HREB |
PLCO |
Aug 9, 2012 |
2012-0355 |
